Compare MTSI & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTSI | MDAIW |
|---|---|---|
| Founded | 1950 | N/A |
| Country | United States | United States |
| Employees | N/A | 78 |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | N/A |
| IPO Year | 2012 | N/A |
| Metric | MTSI | MDAIW |
|---|---|---|
| Price | $174.73 | $0.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $175.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 35.6K |
| Earning Date | 02-05-2026 | 02-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $967,258,000.00 | $27,264,000.00 |
| Revenue This Year | $18.17 | N/A |
| Revenue Next Year | $12.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 32.58 | ★ 44.52 |
| 52 Week Low | $84.00 | $0.08 |
| 52 Week High | $190.95 | $0.90 |
| Indicator | MTSI | MDAIW |
|---|---|---|
| Relative Strength Index (RSI) | 53.93 | 44.42 |
| Support Level | $183.52 | $0.45 |
| Resistance Level | $190.21 | $0.59 |
| Average True Range (ATR) | 6.71 | 0.08 |
| MACD | -1.36 | 0.01 |
| Stochastic Oscillator | 39.69 | 29.90 |
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.